CAS 102519-34-6: Olean-12-en-28-oicacid, 2,3,23-trihydroxy-, (2a,3a,4a)-

2,3,23-Trihydroxy-12-oleanen-28-oic acid is a saponin, which is a type of bioactive compound known for its diverse therapeutic properties. This compound is typically derived from specific plant sources, particularly the genus Camellia, through extraction and purification processes aimed at isolating its active components. The mode of action of 2,3,23-Trihydroxy-12-oleanen-28-oic acid involves modulation of inflammatory pathways, specifically influencing the production of pro-inflammatory cytokines and inhibiting enzymes associated with inflammatory responses. This mechanism positions the compound as a potential anti-inflammatory agent with applicability in various biomedical fields. In terms of uses and applications, 2,3,23-Trihydroxy-12-oleanen-28-oic acid shows promise in the development of anti-inflammatory drugs, offering therapeutic benefits in treating conditions characterized by excessive inflammation such as arthritis or certain autoimmune disorders. Its study also extends into oncology, where its modulatory effects on cellular pathways may offer insights into novel cancer treatments. Ongoing research aims to elucidate further details of its efficacy, pharmacokinetics, and safety profile.

2β,3β,23α-Trihydroxy-12-oleanen-28-oic acid shows cytotoxic activities to human lung adenocarcinoma(A-549)cell lines.